Navigation Links
Oncolytics Biotech Inc. announces approval for UK clinical trial
Date:10/24/2007

CALGARY, AB, --- October 24, 2007 - Oncolytics Biotech Inc. (Oncolytics) (TSX:ONC, NASDAQ:ONCY) announced that it has received a letter of approval from the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) for its Clinical Trial Application (CTA) to begin a clinical trial using intravenous administration of REOLYSIN® in combination with cyclophosphamide, a chemotherapeutic agent as well as immune modulator, in patients with advanced cancers. The Principal Investigators are Dr. James Spicer of Kings College in London, Dr. Johann de Bono and Dr. Kevin Harrington of The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London, and Professor Hardev Pandha of the Royal Surrey County Hospital NHS Trust, Surrey and Mount Alvernia Hospitals.

The Company also intends to host a conference call Wednesday, October 24, 2007 to provide an update on its expanding clinical program. The dial-in details appear below.

We are really looking forward to treating patients in this trial, said Principal Investigator Dr. James Spicer. The hope is that it will provide valuable information about the relationship between oncolytic viral therapy and the immune response of the patient.

The trial (REO 012) is an open-label, dose-escalating, non-randomized trial of REOLYSIN® given intravenously with escalating doses of cyclophosphamide. A standard dose of REOLYSIN® is administered intravenously over five consecutive days, while an intravenous dose of cyclophosphamide is administered three days before REOLYSIN® treatment and continues through the course of the treatment cycle. The total number of patients studied will depend on the number of dose levels tested, but it is anticipated to be approximately 30 patients.


'/>"/>

Contact: Cathy Ward
cathy.ward@oncolytics.ca
403-670-7370
Oncolytics Biotech Inc.
Source:Eurekalert

Page: 1

Related medicine news :

1. Biotechnology industry expected to grow into a three billion dollar industry by 2002
2. Biotechnology on the lead
3. Panacea Biotech To Market Anthrax Vaccine
4. Commercialization of Biotech Discoveries, An Encouragement For Researchers
5. Biotech drug causing anemia-EPREX
6. Leading Biotech Companies Are Interested In Acquisition Of Smaller Companies
7. Biologicals Transfer Proposal between US and Indian Biotechnology
8. Finland and India to interact and cooperate in the filed of telemedicine and biotechnology
9. Vical Biotech and NIH jointly develops HIV vaccine
10. Biotechnology Initiatives Planned In Hyderabad
11. Biotech Osiris to go public
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/1/2015)... New York, New York (PRWEB) March 01, 2015 ... Wright Profemur hip lawsuit (( http://www.consumerinjurylawyers.com/wright-profemur-hip-replacement ) scheduled ... that the defense must prepare a witness to ... implant played in the development of the Profemur ... Order filed in U.S. District Court, Northern District ...
(Date:3/1/2015)... The number of transvaginal mesh lawsuits ... few weeks in two New Jersey litigations where attorneys ... Firm announces. , A Case List updated on ... County proceeding established for products manufactured by Johnson & ... earlier, when 90 fewer cases had been centralized. Additionally, ...
(Date:3/1/2015)... March 01, 2015 ERISAPros ... and Carolyn Roddy to the professional staff of its ... graduated from The Ohio State University-Mortiz College of Law. ... of experience working with several Fortune 500 companies as ... area of corporate benefits. Her experiences range from benefit ...
(Date:3/1/2015)... (PRWEB) March 01, 2015 Theme and ... new transition pack for Final Cut Pro ... accordion style transitions to any FCPX editors project.” Said ... our users the tools needed to easily drag and ... The user gets many different controls over the parameters ...
(Date:2/28/2015)... Malaysia (PRWEB) February 28, 2015 The ... all across Malaysia into one platform and gears towards ... , A series of group talks in smaller ... like Nation Building, Education, Personal Development, Leadership, Entrepreneurship, Healthcare, ... and raise awareness of Malaysian youths. , ...
Breaking Medicine News(10 mins):Health News:Wright Profemur Hip Lawyers at Bernstein Liebhard LLP Comment on Court’s Decision Regarding Testimony Pertaining to Prototype for Profemur Hip Replacement 2Health News:Wright Profemur Hip Lawyers at Bernstein Liebhard LLP Comment on Court’s Decision Regarding Testimony Pertaining to Prototype for Profemur Hip Replacement 3Health News:Bernstein Liebhard LLP Comments on Case List Growth in New Jersey Transvaginal Mesh Litigations, Where Firm Attorneys are Representing Hundreds 2Health News:Bernstein Liebhard LLP Comments on Case List Growth in New Jersey Transvaginal Mesh Litigations, Where Firm Attorneys are Representing Hundreds 3Health News:Bernstein Liebhard LLP Comments on Case List Growth in New Jersey Transvaginal Mesh Litigations, Where Firm Attorneys are Representing Hundreds 4Health News:ERISAPros Recruits Evelyn King, J.D. and Carolyn Roddy, J.D. to its Professional Staff 2Health News:Announcing a New Transition Pack from Pixel Film Studios, Transccordion for Final Cut Pro X 2Health News:My Mobile University Appointed Learning Partner for the Upcoming MCA’S First Youth Empowerment Conference Held in Malaysia on March 28, 2015 2Health News:My Mobile University Appointed Learning Partner for the Upcoming MCA’S First Youth Empowerment Conference Held in Malaysia on March 28, 2015 3Health News:My Mobile University Appointed Learning Partner for the Upcoming MCA’S First Youth Empowerment Conference Held in Malaysia on March 28, 2015 4
... & Master Aesthetician in partnership with Medical Director, Betsy Vasquez, MD announced ... in Leesburg, VA, located at the Fort Evans Plaza II. ... ... and Medspa visionary announced today that AVIE! Medspa and Laser Center is ...
... that Gov. Kathleen Sebelius, nomination to Health and ... end of April, American Life League called on ... reject the nomination.(Logo: http://www.newscom.com/cgi-bin/prnh/20081105/DC44231LOGO ... longstanding Senate tradition only confirming nominees if their ...
... The fruit, combined with contraceptive pill and a genetic ... THURSDAY, April 2 (HealthDay News) -- A rare set ... a genetic mutation almost cost a 42-year-old woman her ... driving in the car one afternoon," said Dr. Lucinda ...
... AMICAS, presence in the image and information management marketBOSTON, ... ) a leader in radiology and medical image and ... the acquisition of Emageon Inc. (Nasdaq: EMAG ... )"AMICAS and Emageon have a shared vision that ...
... MSU chemist Kevin Walker describes how he uses enzymes to make anti-cancer drug paciltaxel. , ... more information. , , , ... , , , ... , , , , ...
... April 2 Streamline Health Solutions, Inc. (Nasdaq: ... and fiscal year 2008 financial results for the period ended ... market closes. The Company will conduct a conference call ... 9 at 4:30 p.m. ET.Interested parties can access the call ...
Cached Medicine News:Health News:Top Medical Team Launches AVIE! Medspa & Laser Center in Leesburg, VA 2Health News:Top Medical Team Launches AVIE! Medspa & Laser Center in Leesburg, VA 3Health News:A.L.L. Calls on KS Senators to Stop Sebelius as Confirmation Postponed 2Health News:Grapefruit-Heavy Diet Helped Spur Dangerous Clot 2Health News:Grapefruit-Heavy Diet Helped Spur Dangerous Clot 3Health News:AMICAS Announces Completion of Merger with Emageon 2Health News:AMICAS Announces Completion of Merger with Emageon 3Health News:AMICAS Announces Completion of Merger with Emageon 4Health News:'Green chemistry' could ease manufacture, boost usefulness of cancer drug 2Health News:'Green chemistry' could ease manufacture, boost usefulness of cancer drug 3Health News:Streamline Health to Announce Q4 and Fiscal Year 2008 Financial Results on Thursday, April 9, 2009 2Health News:Streamline Health to Announce Q4 and Fiscal Year 2008 Financial Results on Thursday, April 9, 2009 3
(Date:3/1/2015)... 2015  Patients suffering from chronic plantar fasciitis ... foot ailment, according to research presented at the ... Scientific Meeting . Researchers utilized ultrasound imaging and ... diseased fasciitis tissue. Permanently removing damaged, pain-generating tissue ... its place, restoring normal function. "Plantar ...
(Date:2/27/2015)... 2015 Roughly three-quarters of pharmacists said ... an interchangeable biosimilar for its branded biologic counterpart ... name, according to a survey published in the ... of Managed Care & Specialty Pharmacy (JMCP). ... pharmacists would feel as confident if the products ...
(Date:2/27/2015)... 2015 The role of the Medical Science ... thing hasn,t changed: face-to-face meetings are seen as the ... Opinion Leaders. Yet at the same time ... of interaction, field medical teams within the pharmaceutical sector ... is just one of the challenges addressed in " ...
Breaking Medicine Technology:Interventional radiology treatment relieves chronic plantar fasciitis 2Interventional radiology treatment relieves chronic plantar fasciitis 3Survey Published in AMCP's JMCP Finds Pharmacists Are Most Confident Substituting Interchangeable Biosimilars for Brand Biologics When Products Share Nonproprietary Name 2Improving the Management of MSL Teams to Create Value across a Diverse Set of Customers 2
... ASHBURN, Va. , July 13 Innocoll, Inc. announced ... Protocol Assessment (SPA) for a proposed phase 3 clinical trial to ... the adjuvant treatment of infected diabetic foot ulcers. , ... The protocol was developed ...
... 12 Crux Biomedical® was named one of "50 Companies to ... survey, conducted by Medical Device and Diagnostics Industry (MD+DI), was published in ... to identify firms that have either achieved success or have the potential ... , , ...
Cached Medicine Technology:Innocoll Submits SPA for Cogenzia(TM) Phase III Clinical Trials for the Adjuvant Treatment of Diabetic Foot Infections 2Innocoll Submits SPA for Cogenzia(TM) Phase III Clinical Trials for the Adjuvant Treatment of Diabetic Foot Infections 3Crux Biomedical Named One of Top 50 Companies to Watch 2
Gills Colibri forceps, very fine pointed tips....
Fine tying forceps, curved tips, wide handle....
Castroviejo tying forceps, tying platforms, straight, 0.3 mm teeth....
Microsurgical curved forceps made of titanium has curved shafts with smooth working surface. TCI working parts 6 mm from tips with round handle, diam. 6 mm, overall length 116 mm....
Medicine Products: